Clinical trial · Observational
Case Series Study of Biliary Tract Cancer Patients in Japan
Retrospective Analysis of the Difference of Prognosis Between Unresectable and Recurrent Biliary Tract Cancer
NCT01294085CI-TRIAL-00005817completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the difference of prognosis between unresectable and recurrent biliary tract cancer and evaluate prognostic factors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biliary Tract Cancer | Malignant Biliary Tract Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- One year survival rate
- timeFrame
- 1 year
Secondary outcomes (3)
- measure
- Overall survival time
- timeFrame
- 3 years
- measure
- Number of participants with adverse events
- timeFrame
- 3 years
- measure
- Progression free survival
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Unresectable or recurrent biliary tract cancer Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.